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In our Select pages, we highlight exciting themes that emerge from our review of the recent literature. In this
issue’s ImmunologySelect,wediscuss acluster of recent papers that further our understandingof thehost innate
immune response to viruses and provide an example of the evasion of the immune response by a viral protein.TRAF3 and the Antiviral Immune Response
The innate immune response is an early line of defense against invading pathogens. This response is mediated
largely by members of the Toll-like receptor (TLR) family, which depend on adaptor proteins, such as MyD88 and
TRIF, to mediate downstream signaling events. Activation of TLRs culminates in the activation of transcription fac-
tors, such as NF-kB and IRF3, that induce production of both pro- and anti-inflammatory cytokines and interferons
(IFNs) by macrophages and dendritic cells. Different TLRs respond to different molecules, for example, TLR4 recog-
nizes lipopolysaccharide (a component of the cell wall of Gram negative bacteria; LPS) and TLR3 recognizes the
double-stranded (ds)RNA genome of viruses. Elucidating the function of the adaptor proteins downstream of
TLRs is crucial for deciphering the specificity of the innate immune response. Oganesyan et al. now characterize
the adaptor protein TRAF3. They show that this protein is unexpectedly a key molecule in both the TLR-dependent
and TLR-independent production of type I IFNs. The authors first tested the involvement of TRAF3 in TLR signaling
by stimulating macrophages frommouse bone marrow that lack TRAF3 with a synthetic dsRNA or LPS (agonists for
TLR3 and TLR4, respectively). They found reduced expression of the gene that encodes IFN-b in thesemacrophages
indicating that TRAF3 is downstream of both TLR3 and TLR4. The authors show that TRAF3 is important for TLR3-
mediated inhibition of the replication of murine g-herpes virus 68 and vesicular stomatitis virus (VSV) indicating that
this adaptor protein is involved in the antiviral response. As the TRIF adaptor protein is crucial for TLR3- and TLR4-
dependent IFN production, the authors examined whether there was a connection between TRIF and TRAF3. In-
deed, TRAF3 associates with TRIF and its downstream effector kinases TBK1 and IKK-3, and enhanced the ability
of these proteins to activate the Ifnb promoter. TRAF3 is also important for the nuclear localization of the transcrip-
tion factor IRF3, whichmodulates expression of the gene encoding IFN-b. Therefore, TRAF3 is a critical adaptor pro-
tein for TRIF-mediated activation of IRF3 and for IFN-b production. The authors also show that TRAF3 is involved in
the production of Type I IFNs mediated by TLR7/9 in response to synthetic agonists in dendritic cells. Furthermore,
in mouse embryonic fibroblasts that lack TLRs, TRAF3 still is required for the production of Type I IFNs and for in-
hibition of viral replication, probably through its interactions with cytoplasmic viral receptors such as PKR. Therefore,
TRAF3 is involved in both the TLR-dependent and TLR-independent aspects of innate immunity and inmultiple path-
ways of IFN activation. Deciphering the regulation of TRAF3 will be key to understanding how this molecule is able to
coordinate specific outcomes of these different signaling pathways.
G. Oganesyan et al. (2005). Nature. Published online 23 November, 2005. 10.1038/nature04374.
TRAF3: A Bridge to Multiple Signaling Pathways
In a complementary study, Ha¨cker et al. report that TRAF3 associates with the activated TLR adaptor MyD88.
Activation ofMyD88 by the agonists CpG-DNA or Pam3Cys—which activate TLR9 and TLR2, respectively—induced
association of TRAF3withMyD88. Interestingly, LPS and synthetic dsRNA—molecules that activate TLR4 and TLR3,
respectively—induce association of TRAF3with the TLR adaptor TRIF. Therefore, TRAF3 is part of bothMyD88- and
TRIF-dependent signaling complexes. Production of the anti-inflammatory cytokine interleukin (IL)-10 and type I
IFNs was markedly reduced when TRAF3-deficient macrophages from mouse bone marrow were stimulated, indi-
cating that TRAF3 is important for the anti-inflammatory cytokine and IFN response to many different pathogen-
derived molecules. These findings concur with those of Oganesyan et al. and both studies show that, in the absence
of TRAF3, IFN production is reduced and VSV infection does not elicit an antiviral response. Ha¨cker et al. next com-
pared TRAF3with the TRAF6 adaptor (known to be important in TLR signaling). They show that TRAF6 is important in
TLR-dependent signaling through MyD88 but not through TRIF, whereas TRAF3 is important in both pathways. The
authors propose that activated MyD88 recruits both TRAF3 and TRAF6. TRAF6 is required for the production of pro-
and anti-inflammatory cytokines, whereas TRAF3 is selectively involved in the production of Type I IFNs and anti-
inflammatory cytokines. Therefore, production of these two opposing types of cytokines, previously thought to be
temporally distinct events, appears to occur simultaneously. This suggests that the TRAF3 and TRAF6 adaptor pro-
teins must be regulated appropriately to ensure an efficient immune response.
H. Ha¨cker et al. (2005). Nature. Published online 23 November, 2005. 10.1038/nature04369.
B-form DNA Bypasses the Toll
Nucleic acids from pathogens induce dendritic cells to produce IFN-a through the activation of various TLRs. For
example, dsRNA, ssRNA, and CpG-DNA are recognized by TLR3, TLR 7/8, and TLR9, respectively. It has been pre-
sumed that the only way that DNA activates the innate immune response is through a TLR. Now Ishii et al. show that
B-form dsDNA [such as poly(dA-dT)poly(dT-dA)] activates interferon production independently of both TLR and
RIG-1, a cytoplasmic receptor that recognizes dsRNA in a TLR-independent manner. Instead, IFN production inCell 124, 5–7, January 13, 2006 ª2006 Elsevier Inc. 5
response to B-DNA is fully dependent on the downstream signaling molecule TBK1 and partly dependent on IKKi—
serine/threonine kinases that are essential for type I IFN production in response to dsRNA generated during viral rep-
lication—as well as partly dependent on IPS-1 (also called MAVS or Cardif), an adaptor molecule downstream of
RIG-1. Interestingly, B-DNA activates the transcription factor IRF3 and the ifnb promoter through TBK1 and IKKi;
however, NF-kB activation induced by B-DNA is independent of these two serine/threonine kinases. Importantly,
genomic DNA purified from modified vaccinia virus Ankara (MVA) stimulated Type I IFN production in wild-type
mouse embryonic fibroblasts but not in those lacking both TBK1 and IKKi. Furthermore, wild-typemouse embryonic
fibroblasts, but not those lacking both TBK1 and IKKi, that had been stimulated withMVADNAwere resistant to sub-
sequent MVA infection. Additionally, B-DNA also stimulated dendritic cells through TBK1. Thus, B-DNA is able to
bypass TLR and RIG-1 to mount an antiviral response. Elucidating how this signal is relayed to TBK1, IPS-1, and
IKKi and identifying the upstream molecular sensors will promote our understanding of the immune response to
DNA and may shed light on mechanisms of autoimmunity.
K.J. Ishii et al. (2006). Nature Immunology 7, 40–48. Published online 13 November 2005. 10.1038/ni1282.
Target My Enemy, Not Me
In a recent study, Barton et al. provide some insights into how the immune system distinguishes between self
and nonself. They examine TLR9, an intracellular TLR that recognizes viral DNA. This TLR is localized primarily to
the endoplasmic reticulum and is targeted to lysosomes when activated by the agonist CpG-DNA. Localization
to the endoplasmic reticulum depends on the transmembrane region of this receptor. The authors report that mis-
directing this receptor to the plasma membrane results in recognition of self-DNA and CpG-DNA but not viral DNA
packaged into capsids. Recognition of packaged DNA of herpes virus type 2 (HSV-2) requires the intracellular
localization of TLR9 and the acidification of the lysosomal compartment. These findings indicate that the recognition
of self-DNA can be avoided by the localization of TLR9 to intracellular compartments and by extracellular degrada-
tion of self-DNA (due to secretion of DNase I). Both the Ishii et al. and Barton et al. studies have important implica-
tions for understanding autoimmune diseases, where the immune system is activated by self antigens. Additionally,
similar mechanisms must exist to enable the immune system to distinguish between self and non-self RNA and we
eagerly await the characterization of these pathways.
G.M. Barton et al. (2006). Nature Immunology 7, 49–56. Published online 11 December 2005. 10.1038/ni1280.
The Virus Strikes Back
Myxoma virus is a poxvirus that causes a lethal systemic disease
called myxomatosis in rabbits. This virus produces many immuno-
modulatory proteins that interfere with the rabbit immune response
and the inflammatory response to viral infection. The product of the
viral M13L gene, M13L-PYD, resembles cellular proteins involved in
apoptosis and inflammation. PYD proteins have a PYRIN domain
that exists in a number of cellular apoptotic and inflammatory regula-
tors. Viruses lacking the M13L gene cannot spread in the infected
rabbit as they are unable to invade peripheral blood leukocytes. Inter-
estingly, however, primary necrotic lesions progress faster in rabbits
infected with myxoma virus lacking M13L compared to rabbits in-
fected with the wild-type virus. Infiltration of inflammatory cells into
viral lesions is increased in the absence of M13L-PYD, as seen by
the upregulation of proinflammatory cytokines IL-1b and IL-18. The
M13L-PYD protein (fused to the green fluorescent protein as a marker) has a perinuclear distribution (see the Figure,
left), which is the localization pattern of PYD family members that associate with ASC-1, a host protein that forms
a complex with caspase-1 and other factors to form the ‘‘inflammasome.’’ The inflammasome is involved in proin-
flammatory cytokine production and may be the target of M13L-PYD. Indeed, M13L-PYD interacts and colocalizes
with ASC-1 (see the Figure, right). Additionally, M13-PYD blocks activation of caspase-1. The authors propose
a model in which M13L-PYD interferes with the formation of the inflammasome by mimicking cellular regulators,
thereby blocking the apoptotic and inflammatory response to viral infection.
J.B. Johnston et al. (2005). Immunity 23(6):587–598.
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(Left) The distribution of M13L-PYD fused to the
green fluorescent protein (GFP) in the cell is
perinuclear. (Right) M13L-PYD-GFP (green) and
Myc/his-tagged ASC-1 (red) colocalize in the
cell (yellow). Nuclei (blue) are stained with DAPI.Cell 124, 5–7, January 13, 2006 ª2006 Elsevier Inc. 7
